Medications for type 1 diabetes primarily focus on replacing insulin, as the body cannot produce it on its own. They include short-acting, rapid-acting, intermediate-acting, long-acting, and ...

Roche’s anti-TIGIT drug tiragolumab has failed a lung cancer study, denting enthusiasm for the programme just as there were signs that it was getting back on track after a series of disappointing ...